Brief: Reg-Herantis Pharma Initiates Non-Invasive CDNF Development Program

Herantis Pharma Oyj

06/07/2018 07:06

July 6 (Reuters) - Herantis Pharma Oyj  HRTIS.HE :
    * REG-HERANTIS PHARMA INITIATES NON-INVASIVE CDNF DEVELOPMENT PROGRAM, ANNOUNCES LICENSING
AGREEMENT WITH UNIVERSITY OF HELSINKI
    * IN CONJUNCTION, HERANTIS AND UNIVERSITY OF HELSINKI HAVE SIGNED A LICENSING AGREEMENT
    * TARGET INDICATIONS FOR POSSIBLE FUTURE CLINICAL DEVELOPMENT HAVE NOT BEEN DISCLOSED.

Source text for Eikon:  ID:nGNE8dLSFg 
Further company coverage:  HRTIS.HE 

 (Gdynia Newsroom)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))